These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 34609056

  • 1. TQFL12, a novel synthetic derivative of TQ, inhibits triple-negative breast cancer metastasis and invasion through activating AMPK/ACC pathway.
    Wei C, Zou H, Xiao T, Liu X, Wang Q, Cheng J, Fu S, Peng J, Xie X, Fu J.
    J Cell Mol Med; 2021 Nov; 25(21):10101-10110. PubMed ID: 34609056
    [Abstract] [Full Text] [Related]

  • 2. Design, Synthesis, and Acute Toxicity Assays for Novel Thymoquinone Derivative TQFL12 in Mice and the Mechanism of Resistance to Toxicity.
    Li T, Tan Q, Wei C, Zou H, Liu X, Mei Z, Zhang P, Cheng J, Fu J.
    Molecules; 2023 Jun 30; 28(13):. PubMed ID: 37446810
    [Abstract] [Full Text] [Related]

  • 3. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3.
    Ünal TD, Hamurcu Z, Delibaşı N, Çınar V, Güler A, Gökçe S, Nurdinov N, Ozpolat B.
    Anticancer Agents Med Chem; 2021 Jun 30; 21(3):355-364. PubMed ID: 32767958
    [Abstract] [Full Text] [Related]

  • 4. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.
    Kabil N, Bayraktar R, Kahraman N, Mokhlis HA, Calin GA, Lopez-Berestein G, Ozpolat B.
    Breast Cancer Res Treat; 2018 Oct 30; 171(3):593-605. PubMed ID: 29971628
    [Abstract] [Full Text] [Related]

  • 5. Thymoquinone inhibits the metastasis of renal cell cancer cells by inducing autophagy via AMPK/mTOR signaling pathway.
    Zhang Y, Fan Y, Huang S, Wang G, Han R, Lei F, Luo A, Jing X, Zhao L, Gu S, Zhao X.
    Cancer Sci; 2018 Dec 30; 109(12):3865-3873. PubMed ID: 30259603
    [Abstract] [Full Text] [Related]

  • 6. XS-2, a novel potent dual PI3K/mTOR inhibitor, exhibits high in vitro and in vivo anti-breast cancer activity and low toxicity with the potential to inhibit the invasion and migration of triple-negative breast cancer.
    Xu S, Sun X, Luo L, Yang Y, Guo Q, Tang S, Jiang Z, Li Y, Han J, Gan W, Yang F, Zhang X, Liu Y, Sun C, He J, Liu M, Zuo D, Zhu W, Wu Y.
    Biomed Pharmacother; 2022 Nov 30; 155():113537. PubMed ID: 36113258
    [Abstract] [Full Text] [Related]

  • 7. Induction of AMPK activation by N,N'-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers.
    Johnson J, Rychahou P, Sviripa VM, Weiss HL, Liu C, Watt DS, Evers BM.
    PLoS One; 2019 Nov 30; 14(3):e0209392. PubMed ID: 30875375
    [Abstract] [Full Text] [Related]

  • 8. Thymoquinone inhibits tumor growth and induces apoptosis in a breast cancer xenograft mouse model: the role of p38 MAPK and ROS.
    Woo CC, Hsu A, Kumar AP, Sethi G, Tan KH.
    PLoS One; 2013 Nov 30; 8(10):e75356. PubMed ID: 24098377
    [Abstract] [Full Text] [Related]

  • 9. VSP‑17 suppresses the migration and invasion of triple‑negative breast cancer cells through inhibition of the EMT process via the PPARγ/AMPK signaling pathway.
    Xu X, Liu M, Yang Y, Wei C, Zhang X, Song H, Wang Y, Duan X.
    Oncol Rep; 2021 Mar 30; 45(3):975-986. PubMed ID: 33650675
    [Abstract] [Full Text] [Related]

  • 10. Thymoquinone, a bioactive component of black caraway seeds, causes G1 phase cell cycle arrest and apoptosis in triple-negative breast cancer cells with mutant p53.
    Sutton KM, Greenshields AL, Hoskin DW.
    Nutr Cancer; 2014 Mar 30; 66(3):408-18. PubMed ID: 24579801
    [Abstract] [Full Text] [Related]

  • 11. Mechanistic Study on Thymoquinone Conjugated ZnO Nanoparticles Mediated Cytotoxicity and Anticancer Activity in Triple-Negative Breast Cancer Cells.
    Banupriya SK, Kavithaa K, Poornima A, Sumathi S.
    Anticancer Agents Med Chem; 2022 Mar 30; 22(2):313-327. PubMed ID: 33845751
    [Abstract] [Full Text] [Related]

  • 12. Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells.
    Adinew GM, Messeha SS, Taka E, Badisa RB, Antonie LM, Soliman KFA.
    Nutrients; 2022 May 19; 14(10):. PubMed ID: 35631261
    [Abstract] [Full Text] [Related]

  • 13. Thymoquinone upregulates IL17RD in controlling the growth and metastasis of triple negative breast cancer cells in vitro.
    Khan MA, Zheng M, Fu J, Tania M, Li J, Fu J.
    BMC Cancer; 2022 Jun 27; 22(1):707. PubMed ID: 35761256
    [Abstract] [Full Text] [Related]

  • 14. Tryptophan hydroxylase 1 and 5-HT7 receptor preferentially expressed in triple-negative breast cancer promote cancer progression through autocrine serotonin signaling.
    Gautam J, Banskota S, Regmi SC, Ahn S, Jeon YH, Jeong H, Kim SJ, Nam TG, Jeong BS, Kim JA.
    Mol Cancer; 2016 Nov 21; 15(1):75. PubMed ID: 27871326
    [Abstract] [Full Text] [Related]

  • 15. Preclinical Evaluation of a Novel Orally Available SRC/Raf/VEGFR2 Inhibitor, SKLB646, in the Treatment of Triple-Negative Breast Cancer.
    Zheng MW, Zhang CH, Chen K, Huang M, Li YP, Lin WT, Zhang RJ, Zhong L, Xiang R, Li LL, Liu XY, Wei YQ, Yang SY.
    Mol Cancer Ther; 2016 Mar 21; 15(3):366-78. PubMed ID: 26721945
    [Abstract] [Full Text] [Related]

  • 16. Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo.
    Attoub S, Sperandio O, Raza H, Arafat K, Al-Salam S, Al Sultan MA, Al Safi M, Takahashi T, Adem A.
    Fundam Clin Pharmacol; 2013 Oct 21; 27(5):557-69. PubMed ID: 22788741
    [Abstract] [Full Text] [Related]

  • 17. DIF-1 inhibits growth and metastasis of triple-negative breast cancer through AMPK-mediated inhibition of the mTORC1-S6K signaling pathway.
    Seto-Tetsuo F, Arioka M, Miura K, Inoue T, Igawa K, Tomooka K, Takahashi-Yanaga F, Sasaguri T.
    Oncogene; 2021 Sep 21; 40(37):5579-5589. PubMed ID: 34304250
    [Abstract] [Full Text] [Related]

  • 18. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.
    Zhu WQ, Wang J, Guo XF, Liu Z, Dong WG.
    World J Gastroenterol; 2016 Apr 28; 22(16):4149-59. PubMed ID: 27122665
    [Abstract] [Full Text] [Related]

  • 19. Xianlinglianxiafang Inhibited the growth and metastasis of triple-negative breast cancer via activating PPARγ/AMPK signaling pathway.
    Yang X, Yang R, Zhang Y, Shi Y, Ma M, Li F, Xie Y, Han X, Liu S.
    Biomed Pharmacother; 2023 Sep 28; 165():115164. PubMed ID: 37478577
    [Abstract] [Full Text] [Related]

  • 20. The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer.
    Şakalar Ç, İzgi K, İskender B, Sezen S, Aksu H, Çakır M, Kurt B, Turan A, Canatan H.
    Tumour Biol; 2016 Apr 28; 37(4):4467-77. PubMed ID: 26500095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.